Petros Pharmaceuticals Inc (NASDAQ: PTPI) Emerges As Guiding Light For Investors

Petros Pharmaceuticals Inc (NASDAQ:PTPI) currently has a daily average trading volume of 36.02M but it saw 9296775 shares traded in last market. With a market cap of 3.86M USD, the company’s current market price of $0.07 came falling about -14.29 while comparing to the previous closing price of $0.08. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.22 and as low as $0.05. In the recent trading on the day, stock has struck highest price mark of $0.067 while lowest mark touched by it was $0.0784.

Taking a look at 20-day trading activity of Petros Pharmaceuticals Inc (PTPI) gives us an average price of $0.0857, while its current price level is -94.10% below from 52-week high level whereas it is 32.84% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.1626 while that of 200 days or SMA-200 reads an average of $0.3082. A closer look into the stock’s movement over the week reveals that its volatility is standing at 31.56% during that period while stretching the period over a month that decreases to 21.99%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 41.42 which implies that the stock is in neutral territory.

Over the week, PTPI’s stock price is moving -46.67% down while it is -15.29% when we observe its performance for the past one month. Year-to-date it is -81.72% down and over the past year, the stock is showing a downside performance of -94.86%.

The company is expected to be releasing its next quarterly report on 2024-Nov-12, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.

Currently, Petros Pharmaceuticals Inc’s total number of outstanding shares is 29.93M with 6.01% of that held by the insiders while 4.86% of its common stock has been owned by the institutions. Stock’s beta reads 2.08. Stock has a price to sale or P/S ratio amounts to 0.75.